Chemoinformaics analysis of 3,7,11,15-Tetramethylhexadec-1-yn-3-ol
| Molecular Weight | 294.523 | nRot | 12 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 1 |
| Exact Molecular Weight | 294.292 | nRing | 0 |
| Solubility: LogS | -6.135 | nHRing | 0 |
| Solubility: LogP | 6.728 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 59.5401 |
| nHD | 1 | BPOL | 38.1219 |
| QED | 0.45 |
| Synth | 3.712 |
| Natural Product Likeliness | 0.638 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.476 |
| MDCK | 0.0000115 |
| BBB | 0.322 |
| PPB | 0.976587 |
| VDSS | 1.48 |
| FU | 0.0131077 |
| CYP1A2-inh | 0.539 |
| CYP1A2-sub | 0.247 |
| CYP2c19-inh | 0.857 |
| CYP2c19-sub | 0.949 |
| CYP2c9-inh | 0.825 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.376 |
| CYP2d6-sub | 0.033 |
| CYP3a4-inh | 0.758 |
| CYP3a4-sub | 0.262 |
| CL | 5.772 |
| T12 | 0.052 |
| hERG | 0.023 |
| Ames | 0.005 |
| ROA | 0.009 |
| SkinSen | 0.932 |
| Carcinogencity | 0.051 |
| EI | 0.885 |
| Respiratory | 0.212 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.566939 |